Evidence map›Paper›PMID 38623487›Full record

ReviewAsian journal of pharmaceutical sciences2024

Platelet-derived microparticles and their cargos: The past, present and future.

Jingwen Guo, Bufeng Cui, Jie Zheng, Chang Yu, Xuran Zheng, Lixin Yi, Simeng Zhang, Keke Wang

Abstract readReview
In one paragraph

Review in Asian journal of pharmaceutical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Beyond autologousMolecular therapy. Oncology · 2026
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jingwen GuoDepartment of Pharmacy, The First Hospital of China Medical University, Shenyang 110001 China.
Bufeng CuiDepartment of Pharmacy, The First Hospital of China Medical University, Shenyang 110001 China.
Jie ZhengDepartment of Pharmacy, The First Hospital of China Medical University, Shenyang 110001 China.
Chang YuSchool of Pharmacy, China Medical University, Shenyang 110122, China.
Xuran ZhengKey Laboratory of Medical Cell Biology of Ministry of Education, Key Laboratory of Major Chronic Diseases of Nervous System of Liaoning Province, Health Sciences Institute of China Medical University, Shenyang 110122, China.
Lixin YiSchool of Pharmacy, China Medical University, Shenyang 110122, China.
Simeng ZhangDepartment of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.
Keke WangDepartment of Pharmacy, The First Hospital of China Medical University, Shenyang 110001 China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

All eukaryotic cells can secrete extracellular vesicles, which have a double-membrane structure and are important players in the intercellular communication involved in a variety of important biological processes. Platelets form platelet-derived microparticles (PMPs) in response to activation, injury, or apoptosis. This review introduces the origin, pathway, and biological functions of PMPs and their importance in physiological and pathological processes. In addition, we review the potential applications of PMPs in cancer, vascular homeostasis, thrombosis, inflammation, neural regeneration, biomarkers, and drug carriers to achieve targeted drug delivery. In addition, we comprehensively report on the origin, biological functions, and applications of PMPs. The clinical transformation, high heterogeneity, future development direction, and limitations of the current research on PMPs are also discussed in depth. Evidence has revealed that PMPs play an important role in cell-cell communication, providing clues for the development of PMPs as carriers for relevant cell-targeted drugs. The development history and prospects of PMPs and their cargos are explored in this guidebook.

Indexed as

ApplicationHeterogeneityPlatelet-derived particlesPotential and limitations

Identifiers

PMID38623487
PMCPMC11016590

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.